Cardiac Ablation Market Analysis and Forecast to 2031: By Product (Radiofrequency Ablators, Cryoablation Devices, Ultrasound Ablators, Electrical Ablators), Application (Catheter-Based, Open Surgery), End-User (Hospitals, Ambulatory Surgical Centers, Card

Cardiac Ablation Market Analysis and Forecast to 2031: By Product (Radiofrequency Ablators, Cryoablation Devices, Ultrasound Ablators, Electrical Ablators), Application (Catheter-Based, Open Surgery), End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Others), and Region

The global vacuum bearing market was valued at US$ 3.29 billion in 2021 and it is anticipated to grow up to US$ 11.34 billion by 2031, at a CAGR of 13% during the forecast period.

Cardiac ablation, also known as radiofrequency ablation or pulmonary vein ablation, is a treatment for atrial fibrillation. It works by causing small scars in heart tissue with energy or by damaging heart tissue and causing an irregular heartbeat. There are two kinds of ablation: radiofrequency ablation and cryoablation. It works by inserting a long, flexible tube into a vein or artery in the groyne and threading it to the heart to deliver energy in the form of heat. There are numerous factors that can cause cardiac arrhythmia. Pre-existing medical conditions such as diabetes, hypertension, hyperthyroidism, mental stress, heart conditions, old age, and other such factors, as well as lifestyle-related factors such as smoking, alcohol abuse, drug abuse, excessive caffeine consumption, and others, are examples of such factors. Furthermore, certain dietary supplements, herbal treatments, and medications can cause cardiac arrhythmia.

Market Drivers and Trends

The increase in cases of atrial fibrillation among people all over the world is the primary driver of the industry's growth. The global elderly population is growing, which is fueling the growth of the cardiac ablation market. According to the National Library of Medicine, people over the age of 80 are more likely to develop atrial fibrillation, one of the most common types of arrhythmias. Furthermore, according to the Centers for Disease Control and Prevention, nearly 12.1 million people in the United States will have AFib by 2030. As a result, the growing geriatric population base, combined with an increasing number of atrial fibrillation cases, will create lucrative market development opportunities.

Furthermore, the industry's growth will be driven by rising risk factors and advances in the treatment of cardiac rhythm disorders. Growing awareness of better healthcare services, as well as an increase in the number of ablation centers, will boost the overall growth of the cardiac ablation industry. The use of cardiac ablation will increase as healthcare infrastructure improves. These factors are expected to drive the growth of the global Cardiac Ablation Market.

Market Restraints and Challenges

The stringent regulations and the risks associated with cardiac ablation procedures are limiting the market growth. Additionally, the high cost of treatment and investment, as well as the risk of complications associated with the procedure such as damage to blood vessels and damage to heart valves, are potential restraints hindering the global Cardiac Ablation Market growth and further restrict the growth of the market.

Global Cardiac Ablation Market Segmental Overview

The report analyses the global Cardiac Ablation Market based on product, application, end-user, and region.

Global Cardiac Ablation Market by Type

Based on type, it is segmented into radiofrequency ablators, electrical ablators, cryoablation devices, and ultrasound ablators. The ultrasound ablators segment is expected to be the largest segment in the Cardiac Ablation Market in 2021. The increasing in the use of ultrasound technologies in the treatment of cardiovascular diseases and incidence of cardiovascular diseases are major factors driving the segment growth.

Global Cardiac Ablation Market by Application

Based on application, the market is bifurcated into catheter-based, and open surgery. The catheter-based segment dominated the market with 2.3 billion USD in 2021. The increase in the number of catheter-based procedures, as well as the introduction of more advanced ablation techniques, is expected to drive segment growth. According to the American Heart Association, catheter-based ablation procedures have a high success rate of around 90%, a low risk of complications, and a shorter recovery time. As a result, a high success rate will benefit product sales during the analysis period.

Global Cardiac Ablation Market by End-User

Based on end-user, the Cardiac Ablation Market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The cardiac centers segment dominated the market. The increasing number of cardiac centers, as well as the availability of advanced treatments, will drive patient preference toward facility. Furthermore, sophisticated infrastructure catering to the need for critical care or intensive care will have an impact on segmental growth.

Geographical Analysis of Global Cardiac Ablation Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is dominating in the Cardiac Ablation Market. The primary reasons driving the development of the market in this region are the presence of a large number of ablation centers, increasing installation base of advanced cardiac ablation catheters, and ongoing projects.

Asia-Pacific is anticipated to dominate the market in the upcoming years due to the rising incidence of cardiac arrhythmia, leading industry players are expanding their operations in Asian countries, availability of technologically advanced products, and a greater awareness of treatment therapies.

Major Players in the Global Cardiac Ablation Market

The key players studied in the global Cardiac Ablation Market are

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the market, because of the COVID-19 pandemic the procedures have been temporarily prohibited or postponed. Also, supply chain disruptions in several economies also hampered business growth. The setback was caused by the authorities' strict lockdown regulations, as well as disruptions in manufacturing and supply-chain operations during the pandemic period. Furthermore, the increased risk of hospital-acquired infections slowed market growth.

However, cardiac ablation devices were discovered to be extremely beneficial in heart failure cases in COVID-19, increasing demand for these devices in a pandemic situation.

Recent Developments

• In August 2021, Microport partnered with Stereotaxis to distribute the robotic magnetic navigation technology of Sterotaxis in China. The strategy provided the firm with significant market growth opportunities as well as geographical expansion.
• In June 2021, Medtronic has received FDA approval for cryoablation catheters. The device is intended for the treatment of paroxysmal atrial fibrillation as an early rhythm control technique. The strategy assisted the company in expanding its product line and strengthening its customer portfolio.
• In May 2020, Acutus Medical and Biotronik have announced a new collaboration to provide a comprehensive portfolio of electrophysiology, mapping, ablation, and accessory products for catheter-based treatment of cardiac arrhythmias in Europe and Asia.
• On October 2019, AngioDynamics has acquired Eximo Medical, Ltd. This acquisition aided the company in broadening and expanding its portfolio of vascular intervention products.

Frequently Asked QuestionsQ1. How big is the Cardiac Ablation Market?Ans. The global Cardiac Ablation Market size was US$ 3.29 billion in 2021 and is anticipated to reach US$ 11.34 billion in 2031, growing at a rate of 13% from 2022 to 2031.Q2. What is the Cardiac Ablation Market growth rate?Ans. The growth rate of the Cardiac Ablation Market is 13% from 2022 to 2031.Q3. Which region holds a major market share for the Cardiac Ablation Market?Ans. North America holds a major market share of the Cardiac Ablation Market in 2021.Q4. Which segment accounted for the largest Cardiac Ablation Market share?Ans. Based on type, it is segmented into radiofrequency ablators, electrical ablators, cryoablation devices, and ultrasound ablators. The ultrasound ablators segment is expected to be the largest segment in the Cardiac Ablation Market in 2021Q5. Who are the key players in the Cardiac Ablation Market?Ans. The global Cardiac Ablation Market report includes players such as Q6. What are the factors driving the Cardiac Ablation Market growth?Ans. The major factors driving the growth of the market are the increase in cases of atrial fibrillation and advances in the treatment of cardiac rhythm disorders.Q7. What are the key growth strategies of Cardiac Ablation Market players?Ans. The key growth strategies of Cardiac Ablation Market players are product launch, partnerships, and government initiatives.Q8. Which region will provide more business opportunities for the Cardiac Ablation Market during the forecast period?Ans. The North America region will provide more business opportunities for the Cardiac Ablation Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.